Michael Seiden
Algemeen Directeur bij Gladius Therapeutics, Inc.
Profiel
Michael V.
Seiden is the founder of Gladius Therapeutics, Inc. He currently holds positions as Director at Nemucore Medical Innovations, Inc. and Professor at Harvard University.
Previously, he served as President, Chief Executive Officer & Director at The Fox Chase Cancer Center, Chairman-Clinical Research Committee at Dana-Farber, Independent Non-Executive Director at ImpediMed Ltd., President & Chief Medical Officer at US Oncology, Inc. and US Oncology Holdings, Inc., Chief-Clinical Research Unit at The General Hospital Corp., and Chief Medical Officer & Senior Vice President at McKesson Specialty Health, Inc. Seiden received his undergraduate degree from Oberlin College and his doctorate from the University of Washington.
Actieve functies van Michael Seiden
| Bedrijven | Functie | Begin |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Directeur/Bestuurslid | 08-12-2015 |
| Gladius Therapeutics, Inc. | Algemeen Directeur | - |
Eerdere bekende functies van Michael Seiden
| Bedrijven | Functie | Einde |
|---|---|---|
| IMPEDIMED LIMITED | Directeur/Bestuurslid | 20-11-2023 |
US Oncology, Inc.
 US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | President | 01-09-2021 |
McKesson Specialty Health, Inc.
 McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services McKesson Specialty Health, Inc. provides health care services. It serves the oncologists, rheumatologists and other specialty physicians, pharmaceutical and biotech manufacturers and payers. The company is headquartered in The Woodlands, TX. | Hoofd Techniek/Wetenschap/O&O | 01-07-2018 |
The Fox Chase Cancer Center
 The Fox Chase Cancer Center Hospital/Nursing ManagementHealth Services The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA. | President | 28-02-2013 |
US Oncology Holdings, Inc.
 US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services US Oncology Holdings, Inc. operates as a holding company, which offers medical oncology services, cancer center services, pharmaceutical services, and research services. The firm provides comprehensive practice management services for the non-clinical aspects of practice management to affiliated practices in its medical oncology and cancer center services segments. Its healthcare Informatics business collects and analyzes data to provide significant insight into drug performance and patient outcomes for ongoing product development and evaluation. The company was founded in March 2004 and is headquartered in The Woodlands, TX. | President | - |
Opleiding van Michael Seiden
| Oberlin College | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IMPEDIMED LIMITED | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
The Fox Chase Cancer Center
The Fox Chase Cancer Center Hospital/Nursing ManagementHealth Services The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA. | Health Services |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Dana-Farber/Harvard Cancer Center
 Dana-Farber/Harvard Cancer Center Hospital/Nursing ManagementHealth Services Dana-Farber/Harvard Cancer Center engages in the medical research and treatment services. The company is headquartered in Boston, MA. | Health Services |
McKesson Specialty Health, Inc.
McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services McKesson Specialty Health, Inc. provides health care services. It serves the oncologists, rheumatologists and other specialty physicians, pharmaceutical and biotech manufacturers and payers. The company is headquartered in The Woodlands, TX. | Health Services |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
US Oncology Holdings, Inc.
US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services US Oncology Holdings, Inc. operates as a holding company, which offers medical oncology services, cancer center services, pharmaceutical services, and research services. The firm provides comprehensive practice management services for the non-clinical aspects of practice management to affiliated practices in its medical oncology and cancer center services segments. Its healthcare Informatics business collects and analyzes data to provide significant insight into drug performance and patient outcomes for ongoing product development and evaluation. The company was founded in March 2004 and is headquartered in The Woodlands, TX. | Health Services |
US Oncology, Inc.
US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Health Services |
| Gladius Therapeutics, Inc. |